Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study

View ORCID ProfileL. Sigfrid, View ORCID ProfileM. Cevik, E. Jesudason, View ORCID ProfileW.S Lim, View ORCID ProfileJ. Rello, View ORCID ProfileJ. H. Amuasi, View ORCID ProfileF. Bozza, View ORCID ProfileC. Palmieri, View ORCID ProfileD. Munblit, View ORCID ProfileJ.C. Holter, View ORCID ProfileA.B. Kildal, View ORCID ProfileC.D. Russell, View ORCID ProfileA. Ho, View ORCID ProfileL. Turtle, View ORCID ProfileT.M. Drake, View ORCID ProfileA. Beltrame, View ORCID ProfileK. Hann, I.R. Bangura, R. Fowler, View ORCID ProfileS. Lakoh, View ORCID ProfileC. Berry, View ORCID ProfileD.J. Lowe, View ORCID ProfileJ. McPeake, M. Hashmi, View ORCID ProfileA.M. Dyrhol-Riise, C. Donohue, View ORCID ProfileD.R. Plotkin, View ORCID ProfileH. Hardwick, View ORCID ProfileN. Elkheir, View ORCID ProfileN. Lone, View ORCID ProfileA.B. Docherty, View ORCID ProfileE.M. Harrison, View ORCID ProfileK.J. Baille, View ORCID ProfileG. Carson, View ORCID ProfileM.G. Semple, View ORCID ProfileJ.T. Scott
doi: https://doi.org/10.1101/2020.08.26.20180950
L. Sigfrid
1Clinical Research Fellow, Public Health Specialist, ISARIC GSC, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L. Sigfrid
  • For correspondence: louise.sigfrid@gmail.com
M. Cevik
2Infection and Global Health Division, School of Medicine, University of St Andrews, St Andrews, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Cevik
E. Jesudason
3Consultant in Rehabilitation Medicine, NHS Lothian, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W.S Lim
4Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for W.S Lim
J. Rello
5Prof. 1. Centro de Investigación Biomédica en Red – Enfermedades Respiratorias (CIBERES), Vall d’Hebron Institute of Research (VHIR), Barcelona, Spain. 2. Research Department, CHU Nîmes, Université Nîmes-Montpellier, Nîmes, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Rello
J. H. Amuasi
6School of Public Health, Kwame Nkrumah University of Science and Technology and Kumasi Center for Collaborative Research in Tropical Medicine, Ghana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. H. Amuasi
F. Bozza
7Fundação Oswaldo Cruz: Rio de Janeiro, RJ, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Bozza
C. Palmieri
81. Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK; 2. The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Palmieri
D. Munblit
9Associate Prof. 1. Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child’s Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. 2. Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D. Munblit
J.C. Holter
10Specialist in infectious diseases and medical microbiology, 1. Department of Microbiology, Oslo University Hospital, Oslo. 2. Institute of Clinical Medicine, University of Oslo, Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.C. Holter
A.B. Kildal
11Specialist in Anesthesiology, Department of Anesthesiology and Intensive Care, University Hospital of North Norway, Tromsø, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A.B. Kildal
C.D. Russell
12Clinical lecturer in Infectious Diseases, Centre for Inflammation Research, University of Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C.D. Russell
A. Ho
13Clinical Senior Lecturer/Consultant in Infectious Diseases, University of Glasgow, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Ho
L. Turtle
141. Senior clinical lecturer in infectious diseases, NIHR Health Protection Research Unit in emerging and zoonotic infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool. 2. Consultant in infectious diseases, Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L. Turtle
T.M. Drake
15Clinical Research Fellow, Centre for Medical Informatics, University of Edinburgh, Edinburgh, United Kingdom,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T.M. Drake
A. Beltrame
16Clinician, Department of Infectious Diseases, Tropical and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital: Negrar di Valpolicella, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Beltrame
K. Hann
17Sustainable Health Systems, Freetown, Sierra Leone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for K. Hann
I.R. Bangura
18Data Manager, Dorothy Springer Trust, Sierra Leone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Fowler
19Department of Medicine and Department of Critical Care Medicine, Sunnybrook Hospital, University of Toronto. Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Lakoh
20Sustainable Health Systems, Freetown, Sierra Leone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Lakoh
C. Berry
21Prof. Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Berry
D.J. Lowe
22Emergency Department, Queen Elizabeth University Hospital, Glasgow, Scotland, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D.J. Lowe
J. McPeake
231. NHS Greater Glasgow and Clyde 2. University of Glasgow Institute of Health and Wellbeing 3. THIS Institute, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. McPeake
M. Hashmi
241. Critical Care Medicine, Ziauddin University, Karachi, Pakistan 2. Pakistan Registry of Intensive CarE (PRICE), Pakistan. 3. South East Asian Research in Critical care Health (SEARCH)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.M. Dyrhol-Riise
25Prof. Dep. of Infectious Diseases, Oslo University hospital, Institute of Clinical Medicine, University of Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A.M. Dyrhol-Riise
C. Donohue
26Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.R. Plotkin
27ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D.R. Plotkin
H. Hardwick
281. National Institute of Health Research (NIHR) Health Protection research Unit in Emerging and Zoonotic Infections, Liverpool, UK. 2. Institute of Infection and Global Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H. Hardwick
N. Elkheir
29Clinical research fellow, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for N. Elkheir
N. Lone
30Usher Institute, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for N. Lone
A.B. Docherty
311. Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK. 2. 2Intensive Care Unit, Royal Infirmary Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A.B. Docherty
E.M. Harrison
32Prof. Director Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E.M. Harrison
K.J. Baille
33Roslin Institute, University of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for K.J. Baille
G. Carson
34ISARIC, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Carson
M.G. Semple
35Prof. Health Protection Research Unit In Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK 2. Respiratory Medicine, Alder Hey Children’s NHS Foundation Trust, Eaton Road, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M.G. Semple
J.T. Scott
36MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.T. Scott
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Very little is known about possible clinical sequelae that may persist after resolution of the acute Coronavirus Disease 2019 (COVID-19). A recent longitudinal cohort from Italy including 143 patients recovered after hospitalisation with COVID-19 reported that 87% had at least one ongoing symptom at 60 day follow-up. Early indications suggest that patients with COVID-19 may need even more psychological support than typical ICU patients. The assessment of risk factors for longer term consequences requires a longitudinal study linked to data on pre-existing conditions and care received during the acute phase of illness.

Methods and analysis This is an international open-access prospective, observational multi-site study. It will enrol patients following a diagnosis of COVID-19. Tier 1 is developed for following up patients day 28 post-discharge, additionally at 3 to 6 months intervals. This module can be used to identify sub-sets of patients experiencing specific symptomatology or syndromes for further follow up. A Tier 2 module will be developed for in-clinic, in-depth follow up. The primary aim is to characterise physical consequences in patients post-COVID-19. Secondary aim includes estimating the frequency of and risk factors for post-COVID-19 medical sequalae, psychosocial consequences and post-COVID-19 mortality. A subset of patients will have sampling to characterize longer term antibody, innate and cell-mediated immune responses to SARS-CoV-2.

Ethics and dissemination This collaborative, open-access study aims to characterize the frequency of and risk factors for long-term consequences and characterise the immune response over time in patients following a diagnosis of COVID-19 and facilitate standardized and longitudinal data collection globally. The outcomes of this study will inform strategies to prevent long term consequences; inform clinical management, direct rehabilitation, and inform public health management to reduce overall morbidity and improve outcomes of COVID-19.

Strengths and limitations of this study

  • As an international prospective, observational study we provide open-access standardised tools that can be adapted by any site interested in following up patients with COVID-19, for independent or combined analysis, to forward knowledge into short and long term consequences of COVID-19.

  • This study aims to inform strategies to prevent longer term sequalae; inform clinical management, rehabilitation, and public health management strategies to reduce morbidity and improve outcomes.

  • The protocol will be used for a sub-set of patients, already included in the existing cohort of more than 85,973 individuals hospitalized with confirmed COVID-19 infection across 42 countries (as of 20 July 2020), using the ISARIC/WHO standardized Core- or RAPID Case Report Forms (CRFs).

  • The data will be linked with data on pre-existing comorbidities, presentation, clinical care and treatments documented in the existing cohort already documented using the ISARIC/WHO standardized Core- or RAPID CRFs.

  • The data collection tool is developed to facilitate wide dissemination and uptake, by enabling patient self-assessment, however, follow up of patients requires consent and resources, which might limit the uptake and bias the data towards countries /sites with capacity to follow up patients over time.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

osf.io/c5rw3/

Clinical Protocols

https://isaric.tghn.org/CCP/isaric-global-covid-19-long-term-follow-study/

Funding Statement

This work was supported by the Department for International Development and Wellcome [215091/Z/18/Z] and the Bill & Melinda Gates Foundation [OPP1209135]. CP would like to acknowledge the support of the Liverpool Experimental Cancer Medicine Centre (Grant Reference: C18616/A25153) and The Clatterbridge Cancer Centre Charity. CB acknowledges the support from British Heart Foundation RE/18/6134217.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a multi-site global prospective COVID-19 observational follow up study protocol, developed by the ISARIC COVID-19 Global Follow up working group. Each site that sets up the study will seek local ethical approvals as appropriate.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

ISARIC stands by the principles of data sharing in public health emergencies. ISARIC supported studies will share quality data in a timely, valid, and governed manner to inform public health policy and benefit patient care. The ISARIC-hosted data platform enables rapid and harmonised operationalisation of data collection to a secure database. Ownership and control of the data entered are retained by those who enter the data. Sites can contribute data to combined analysis upon permission. Technical appendix, statistical code and datasets are available from https://isaric.tghn.org/ or by contacting: ncov{at}isaric.org.

https://isaric.tghn.org/CCP/isaric-global-covid-19-long-term-follow-study/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 01, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
L. Sigfrid, M. Cevik, E. Jesudason, W.S Lim, J. Rello, J. H. Amuasi, F. Bozza, C. Palmieri, D. Munblit, J.C. Holter, A.B. Kildal, C.D. Russell, A. Ho, L. Turtle, T.M. Drake, A. Beltrame, K. Hann, I.R. Bangura, R. Fowler, S. Lakoh, C. Berry, D.J. Lowe, J. McPeake, M. Hashmi, A.M. Dyrhol-Riise, C. Donohue, D.R. Plotkin, H. Hardwick, N. Elkheir, N. Lone, A.B. Docherty, E.M. Harrison, K.J. Baille, G. Carson, M.G. Semple, J.T. Scott
medRxiv 2020.08.26.20180950; doi: https://doi.org/10.1101/2020.08.26.20180950
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
L. Sigfrid, M. Cevik, E. Jesudason, W.S Lim, J. Rello, J. H. Amuasi, F. Bozza, C. Palmieri, D. Munblit, J.C. Holter, A.B. Kildal, C.D. Russell, A. Ho, L. Turtle, T.M. Drake, A. Beltrame, K. Hann, I.R. Bangura, R. Fowler, S. Lakoh, C. Berry, D.J. Lowe, J. McPeake, M. Hashmi, A.M. Dyrhol-Riise, C. Donohue, D.R. Plotkin, H. Hardwick, N. Elkheir, N. Lone, A.B. Docherty, E.M. Harrison, K.J. Baille, G. Carson, M.G. Semple, J.T. Scott
medRxiv 2020.08.26.20180950; doi: https://doi.org/10.1101/2020.08.26.20180950

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5270)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (360)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5889)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (767)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (143)
  • Occupational and Environmental Health (234)
  • Oncology (480)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (98)
  • Psychiatry and Clinical Psychology (864)
  • Public and Global Health (2023)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)